Canonsburg, Pennsylvania-based Viatris Inc. (VTRS) is a healthcare company that provides a diverse portfolio of branded, ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Viatris faces revenue declines, execution issues, and high debt post-merger. Click here to read my latest analysis of VTRS ...

If you are wondering whether Viatris is quietly undervalued or just a value trap in disguise, you are in the right place and we will unpack what the current price is really telling us. The stock has ...

Shares of Viatris Inc. rallied 1.83% to $12.24 Wednesday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.32% to 6,932.05 and the Dow ...

Viatris is letting go of the equity stake it’s held in Biocon’s biosimilar subsidiary Biocon Biologics for $815 million, allowing Biocon to fully integrate its subsidiary. | Returning its stake in ...

PITTSBURGH, Dec. 6, 2025 /PRNewswire/ -- Viatris Inc. (Nasdaq: VTRS) today announced that it has entered into definitive agreements with Biocon Limited ("Biocon") for the sale of Viatris' equity stake ...